< Back to Find a Trial

A Multicenter, Open-Label, Long-Term Treatment Study of Intravenously Administered BIIB092 in Patients with Progressive Supranuclear Palsy Who Participated in Study CN002003 (251PP201)

ID

NCT02658916

Condition Studied

Progressive Supranuclear Palsy

Phase

Phase I

Status

Closed

Intervention

BIIB092

Principal Investigator

Adam Boxer, MD, PhD

[email protected]

415 - 476 - 0668

Please go to ClinicalTrials.gov for more information.